Chris Ogden ’06 has been promoted to chief financial officer at CytomX Therapeutics, an oncology-focused biopharmaceutical company.
“Chris has made broad contributions as a member of the CytomX executive team and is a proven cross-functional leader within the organization,” said Sean McCarthy, D.Phil., chief executive officer and chairman of CytomX. “We are excited to announce this promotion, which is a reflection of Chris’ financial acumen, strategic leadership and deep commitment to CytomX’s mission.”
While at Wabash he majored in economics, was a member of Sigma Chi, and was a member of the football team.
